Harnessing the Power of Prostacyclins to Improve Patient Outcomes
WHO WE ARE
Experienced team dedicated to improving patient outcomes in medical conditions where there are limited or no treatment options.
OUR SCIENCE
Our focus on Prostacyclin analogues is based on research establishing PGI2 as a potent vasodilator with antiplatelet, antiproliferative and anti-inflammatory properties
PIPELINE
